the

Rain Expands Visa Membership Into Asia-Pacific, Advancing the Reach of Its Global Stablecoin Payment Infrastructure

Rain's expanded issuing footprint enables global consumer and corporate credit card programs across some of the world's most digitally active…

4 hours ago

Agero Receives Frost & Sullivan’s 2025 North American Digitalized Roadside Assistance Services Company of the Year Recognition for Market Leadership Excellence

The company is honored for redefining industrial performance through GenAI copilots, automation, and innovation that deliver measurable returns by improving…

4 hours ago

Littlebird Raises $11 Million to Launch the Only AI That Already Knows What You’re Working On

The seed round, led by Lotus Studio, will scale the AI assistant built on a simple insight: context shouldn't be…

7 hours ago

The 47% premium: How culture predicts market value in the AI era — Findings from Culture Amp

New Culture Amp research tracking 1,800 companies reveals a discrete measurable state of Peak Performance associated with a 36% share…

7 hours ago

NYSE Content Update: The Hill & Valley Forum Convenes Leaders in Washington

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 24, 2026 /PRNewswire/ -- The New York…

7 hours ago

Zocdoc Launches The AI-Informed Patient Report, Revealing How Patient Use of AI Is Reshaping the Patient-Provider Relationship

New findings highlight rising—yet hidden—patient use of AI and surprisingly optimistic providers, pointing to an emerging "triangle of care"NEW YORK,…

11 hours ago

Dupixent (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease…

19 hours ago

Idorsia announces the nomination of three candidates for election to the Board of Directors

Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial expertise for election at the Annual General Meeting…

19 hours ago

Press Release: Sanofi and Regenerons Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in…

19 hours ago

Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers

BEIJING, March 24, 2026 /PRNewswire/ -- During the Upperside World Congress 2026, Huawei hosted its IP Gala summit themed "Next-Generation WAN,…

19 hours ago